MK-8291

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-8291, covering 2019-12-09 to 2019-12-09. Get the full timeline:

Most recent: Clinical Trial Update: The Efficacy of MK-8291 in Participants With Post-herpetic Neuralgia (PHN) With Allodynia (MK-8291-012) [Phase 1]